https://www.selleckchem.com/pr....oducts/ly2606368.htm
Fractalkine levels progressively increased with the severity of the disease in the HFrEF group (NYHA I 471.2±52.4pg/ml, NYHA II 500.5±38.4pg/ml, NYHA III 638.9±54.3pg/ml, p for linear trend 0.023). Numerically higher concentrations of fractalkine were observed in the HFrEF group compared to the no HF group with borderline significance (p=0.052). No significant differences in clopidogrel-induced platelet inhibition according to fractalkine values were observed in any of the groups. Fractalkine levels were increased in patients with HFr
Like
Comment
Share
